A detailed history of Prostatis Group LLC transactions in Nike, Inc. stock. As of the latest transaction made, Prostatis Group LLC holds 13,705 shares of NKE stock, worth $869,993. This represents 0.3% of its overall portfolio holdings.

Number of Shares
13,705
Previous 10,552 29.88%
Holding current value
$869,993
Previous $933 Million 11.18%
% of portfolio
0.3%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 21, 2025

BUY
$73.36 - $89.13 $231,304 - $281,026
3,153 Added 29.88%
13,705 $1.04 Billion
Q3 2024

Mar 21, 2025

BUY
$71.09 - $89.44 $125,900 - $158,398
1,771 Added 20.17%
10,552 $933 Million
Q2 2024

Mar 21, 2025

BUY
$75.37 - $97.18 $48,462 - $62,486
643 Added 7.9%
8,781 $676 Million
Q1 2024

Mar 21, 2025

BUY
$92.58 - $107.18 $92,209 - $106,751
996 Added 13.95%
8,138 $765 Million
Q4 2023

Mar 21, 2025

BUY
$94.56 - $122.64 $675,347 - $875,894
7,142 New
7,142 $775 Million

Others Institutions Holding NKE

About NIKE, Inc.


  • Ticker NKE
  • Exchange NYSE
  • Sector Consumer Cyclical
  • Industry Footwear & Accessories
  • Shares Outstandng 1,259,689,984
  • Market Cap $80B
  • Description
  • NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells men's, women's, and kids athletic footwear, apparel, equipment, and accessories worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chu...
More about NKE
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.